Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;14(4):e1554.
doi: 10.1002/wsbm.1554. Epub 2022 Apr 5.

Genetic obstacles to developing and tolerizing human B cells

Affiliations
Review

Genetic obstacles to developing and tolerizing human B cells

Kim Nguyen et al. WIREs Mech Dis. 2022 Jul.

Abstract

Early in development, B cells explosively diversify B-cell receptors (BCRs) to recognize a wide variety of microbial antigens. A variety of developmental and tolerance checkpoints are subsequently deployed at later developmental stages to purge useless or potentially dangerous autoreactive B-cell clones. Once B cells recognize cognate antigens within secondary lymphoid tissues, their BCRs are genetically modified to increase the specificity and strength of antigen binding. Identification and investigation of monogenic inborn errors of immunity (IEI) diseases demonstrate which specific molecules and pathways are essential for developing well-tolerized human B cells. Although rare, IEI patients have provided important mechanistic insights into, and therapeutic clues for, patients afflicted with more common autoantibody associated autoimmune diseases like lupus, rheumatoid arthritis, and type 1 diabetes. This article is categorized under: Immune System Diseases > Stem Cells and Development > Genetics/Genomics/Epigenetics.

Keywords: B cell; germinal center; immune tolerance; inborn error of immunity.

PubMed Disclaimer

References

FURTHER READING
    1. Immunodeficiency search (https://www.immunodeficiencysearch.com) is an excellent, up to date, online reference for practicing (and aspiring) clinical immunologists.
REFERENCES
    1. Afzali, B., Grönholm, J., Vandrovcova, J., O'Brien, C., Sun, H.-W., Vanderleyden, I., Davis, F. P., Khoder, A., Zhang, Y., Hegazy, A. N., Villarino, A. V., Palmer, I. W., Kaufman, J., Watts, N. R., Kazemian, M., Kamenyeva, O., Keith, J., Sayed, A., Kasperaviciute, D., … Laurence, A. D. J. (2017). BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nature Immunology, 18(7), 813-823. https://doi.org/10.1038/ni.3753
    1. Agrawal, A., & Schatz, D. G. (1997). RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell, 89(1), 43-53. https://doi.org/10.1016/S0092-8674(00)80181-6
    1. Allman, D., Li, J., & Hardy, R. R. (1999). Commitment to the B lymphoid lineage occurs before DH-JH recombination. Journal of Experimental Medicine, 189(4), 735-740. https://doi.org/10.1084/jem.189.4.735
    1. Bankovich, A. J., Raunser, S., Juo, Z. S., Walz, T., Davis, M. M., & Garcia, K. C. (2007). Structural insight into pre-B cell receptor function. Science, 316(5822), 291-294. https://doi.org/10.1126/science.1139412
    1. Barmettler, S., Otani, I. M., Minhas, J., Abraham, R. S., Chang, Y., Dorsey, M. J., Ballas, Z. K., Bonilla, F. A., Ochs, H. D., & Walter, J. E. (2017). Gastrointestinal manifestations in X-linked agammaglobulinemia. Journal of Clinical Immunology, 37(3), 287-294. https://doi.org/10.1007/s10875-017-0374-x

Publication types

LinkOut - more resources